- Home
- BBLG vs NDRA Comparison
BBLG vs NDRA Comparison
Compare BBLG & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBLG
- NDRA
- Stock Information
- Founded
- BBLG 2004
- NDRA 2007
- Country
- BBLG United States
- NDRA United States
- Employees
- BBLG N/A
- NDRA N/A
- Industry
- BBLG Industrial Specialties
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BBLG Health Care
- NDRA Health Care
- Exchange
- BBLG Nasdaq
- NDRA Nasdaq
- Market Cap
- BBLG 2.7M
- NDRA 2.3M
- IPO Year
- BBLG N/A
- NDRA 2017
- Fundamental
- Price
- BBLG $3.79
- NDRA $3.52
- Analyst Decision
- BBLG
- NDRA Strong Buy
- Analyst Count
- BBLG 0
- NDRA 1
- Target Price
- BBLG N/A
- NDRA $46.00
- AVG Volume (30 Days)
- BBLG 1.4M
- NDRA 29.5K
- Earning Date
- BBLG 08-08-2025
- NDRA 08-13-2025
- Dividend Yield
- BBLG N/A
- NDRA N/A
- EPS Growth
- BBLG N/A
- NDRA N/A
- EPS
- BBLG N/A
- NDRA N/A
- Revenue
- BBLG N/A
- NDRA N/A
- Revenue This Year
- BBLG N/A
- NDRA N/A
- Revenue Next Year
- BBLG N/A
- NDRA N/A
- P/E Ratio
- BBLG N/A
- NDRA N/A
- Revenue Growth
- BBLG N/A
- NDRA N/A
- 52 Week Low
- BBLG $3.42
- NDRA $2.90
- 52 Week High
- BBLG $25.50
- NDRA $179.20
- Technical
- Relative Strength Index (RSI)
- BBLG 39.68
- NDRA 50.31
- Support Level
- BBLG $3.56
- NDRA $3.41
- Resistance Level
- BBLG $6.19
- NDRA $3.59
- Average True Range (ATR)
- BBLG 0.69
- NDRA 0.18
- MACD
- BBLG -0.18
- NDRA 0.05
- Stochastic Oscillator
- BBLG 7.10
- NDRA 62.30
About BBLG Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.